Stock Watch: Global Issues Sway Big Pharma Stocks In Q4 Earnings Season
But Some Of Pfizer’s Challenges Were Of Its Own Making
Taking a broad view of big pharma share price movements as the sector reported 2024 financials, company-specific issues were complicated by geopolitical factors including Donald Trump’s tariff announcements.
